These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7712019

  • 1. Mechanisms of pulmonary vasoconstriction and bronchoconstriction produced by PAF in the guinea-pig: role of platelets and cyclo-oxygenase metabolites.
    Argiolas L, Fabi F, del Basso P.
    Br J Pharmacol; 1995 Jan; 114(1):203-9. PubMed ID: 7712019
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F, Calabrese R, Stati T, del Basso P.
    Br J Pharmacol; 2001 Oct; 134(4):777-88. PubMed ID: 11606318
    [Abstract] [Full Text] [Related]

  • 3. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J, Rotilio D, Vargaftig BB.
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiopulmonary effects of endothelin-1 in the guinea pig: role of thromboxane A2.
    del Basso P, Argiolas L.
    J Cardiovasc Pharmacol; 1995 Jul; 26 Suppl 3():S120-2. PubMed ID: 8587337
    [Abstract] [Full Text] [Related]

  • 7. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA, Kroegel C, Barnes PJ.
    J Immunol; 1990 May 01; 144(9):3489-97. PubMed ID: 2158510
    [Abstract] [Full Text] [Related]

  • 8. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.
    Lellouch-Tubiana A, Lefort J, Pirotzky E, Vargaftig BB, Pfister A.
    Br J Exp Pathol; 1985 Jun 01; 66(3):345-55. PubMed ID: 3890915
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
    Boukili MA, Bureau M, Lagente V, Lefort J, Lellouch-Tubiana A, Malanchère E, Vargaftig BB.
    Br J Pharmacol; 1986 Oct 01; 89(2):349-59. PubMed ID: 3096407
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological modulation of platelet activating factor (PAF)-induced bronchoconstriction and hypertension in anaesthetized guinea-pigs.
    Iwama T, Shikada K, Tanaka S.
    J Pharm Pharmacol; 1988 Aug 01; 40(8):544-7. PubMed ID: 2907007
    [Abstract] [Full Text] [Related]

  • 11. Bronchoconstriction and eosinophil recruitment in guinea pig lungs after platelet activating factor administration.
    Lin CC, Lin CY.
    J Asthma; 1997 Aug 01; 34(2):153-60. PubMed ID: 9088302
    [Abstract] [Full Text] [Related]

  • 12. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM, Man RY.
    Br J Pharmacol; 1991 Dec 01; 104(4):933-7. PubMed ID: 1810604
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W, Kinnaird AA, Man RY.
    Br J Pharmacol; 1991 May 01; 103(1):1097-102. PubMed ID: 1652337
    [Abstract] [Full Text] [Related]

  • 14. Pertussis toxin attenuates platelet-activating factor-induced pulmonary hemodynamic alterations in pigs.
    Olson NC, Kruse-Elliott KT, Whorton AR, Dodam JR.
    Am J Physiol; 1993 Mar 01; 264(3 Pt 1):L213-21. PubMed ID: 8460710
    [Abstract] [Full Text] [Related]

  • 15. Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4.
    Piper PJ, Stewart AG.
    Br J Pharmacol; 1986 Jul 01; 88(3):595-605. PubMed ID: 3091131
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP, Nourshargh S, Hellewell PG, Williams TJ.
    Br J Pharmacol; 1991 Sep 01; 104(1):251-7. PubMed ID: 1786514
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiological mechanisms responsible for the action of PAF in guinea-pig myocardium. Relation to the putative membrane signalling processes of PAF.
    Gollasch M, Ignatieva V, Kobrinsky E, Vornovitsky E, Zaborovskaya L.
    J Lipid Mediat; 1991 Sep 01; 3(2):139-59. PubMed ID: 1797150
    [Abstract] [Full Text] [Related]

  • 18. Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipoxygenase.
    Toga H, Hibler S, Ibe BO, Raj JU.
    J Appl Physiol (1985); 1992 Dec 01; 73(6):2559-66. PubMed ID: 1490969
    [Abstract] [Full Text] [Related]

  • 19. Action of salicylate on failing heart lung preparations of guinea-pig perfused with red blood cells suspended in Tyrode-dextrane.
    Del Basso P, Iacobacci O, Carpi A.
    Arch Int Pharmacodyn Ther; 1978 Nov 01; 236(1):137-53. PubMed ID: 747460
    [Abstract] [Full Text] [Related]

  • 20. Paf-induced release of spasmogens from guinea-pig lungs.
    Jancar S, Thériault P, Lauzière M, Braquet P, Sirois P.
    Br J Pharmacol; 1989 Jan 01; 96(1):153-62. PubMed ID: 2538179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.